This report has been updated. Click here to view latest edition.

If you have previously purchased the archived report below then please use the download links on the right to download the files.

3D Bioprinting 2017-2027: Technologies, Markets, Forecasts

Opportunities in cosmetics and consumer product testing, drug development and regenerative medicine

Show All Description Contents, Table & Figures List FAQs Pricing Related Content
Interest in 3D bioprinting has been gaining momentum in recent years, both in the academic and commercial settings. Between 2014 and 2015, the market welcomed numerous 3D bioprinting companies, and new start-ups, spin-outs, and subsidiaries are continuing to emerge. Though investment in the field has been driven on by the futuristic goal of providing solutions for regenerative by way of fabricating organs for transplant, more realistic applications in product development and testing have shown great promise and are already being marketed. Over 2016, several 3D bioprinting companies saw a doubling of revenue, and comparable results are anticipated for the next few years. Given these market trends, IDTechEx forecasts that the global market for 3D bioprinting will reach a value of $1.8 billion by the year 2027.
 
Technology and Applications
 
3D bioprinting can be defined in a variety of ways, and each definition includes and excludes large swathes of key biotechnology markets. In this report, IDTechEx has defined 3D bioprinting as the deposition of living cells in a spatially controlled manner in the absence of any pre-existing scaffold and in more than a single layer. Under this definition, 3D bioprinters are currently based on four main printhead technologies:
 
  • Inkjet
  • Extrusion
  • Laser-induced forward transfer
  • Microvalve
 
This report profiles each technology and its subtypes, and provides key specifications, vendors, and SWOT analyses. This report also introduces and discusses emerging 3D bioprinting technologies of electrospinning, optical bioprinting, label-less magnetic levitation, and acoustic levitation. Technologies and considerations relevant to the 3D bioprinting process, such as software, bioink (including cell selection, growth factors, and scaffold materials), and post-printing maturation are also discussed.
 
Current and future applications for 3D bioprinting discussed in this report include:
 
  • Testing of cosmetics and other consumer goods
  • Drug screening
  • Personalised medicine
  • Regenerative medicine
  • Cell-based biosensors
  • Food and other animal products
  • Education
  • Academic research
  • Bionics
 
Regenerative Medicine
 
Special attention is paid to regenerative medicine in this report, as not only does it have the potential to be the largest application for 3D bioprinting in the future, but also one with the highest impact. This report analyses how 3D bioprinting can be applied to regenerative medicine, and focuses on the following tissue types:
 
  • Bone and cartilage
  • Skin
  • Dental
  • Vasculature
  • Complex organs
 
Additionally, discussion of current progress in bringing 3D bioprinted tissues to the clinic is provided, as well future hurdles to be faced. A roadmap of 3D bioprinting in regenerative medicine to the year 2050 is provided.
 
Forecasts
 
This report forecasts the overall 3D bioprinting market to 2027, with in depth discussion of key trends in the short term (2017 - 2021), and those expected in the long term (2022 - 2027). Market forecasts to 2027 are also provided for the 3D bioprinter market segmented by price point, and the 3D bioprinted tissue market segmented by tissue application.
Analyst access from IDTechEx
All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.
Further information
If you have any questions about this report, please do not hesitate to contact our report team at research@IDTechEx.com or call one of our sales managers:

AMERICAS (USA): +1 617 577 7890
ASIA (Japan and Korea): +81 3 3216 7209
EUROPE (UK) +44 1223 812300
1.EXECUTIVE SUMMARY
1.1.Overview
1.2.3D Bioprinting Players
1.3.High Profile Partnerships
1.4.Successful Animal Tests
1.5.3D Bioprinting Market Forecast 2017 - 2027
1.6.3D Bioprinter Market Forecast 2017 - 2027
1.7.3D Bioprinted Tissue Market Forecast 2017 - 2027
1.8.Key Drivers
1.9.Key Challenges
2.INTRODUCTION
2.1.Report Scope / 3D Bioprinting Definition
2.2.3D Bioprinting Process
2.2.1.3D Bioprinting Process: Discussion
2.3.3D Cell Culture Advantages
2.4.3D Bioprinting Advantages
2.5.Key Driver: Regenerative Medicine
2.5.1.Key Driver: Unmet Need in Organs for Transplant
2.6.Key Driver: Product Testing in Medicine
2.6.1.Key Driver: Avoiding Costly Drug Trial Failures
2.7.Key Driver: Product Testing in Consumer Products
2.8.Major Bioprinting Firsts
2.9.3D Bioprinting in 2017
2.10.Key Trends: 3D Bioprinters
2.11.Key Trends: Bioprinted Tissues
2.12.Key Competing Technologies
2.13.Current Technical Challenges
2.14.Current Biological Challenges
2.15.Regulatory Hurdles
2.16.3D Bioprinting SWOT Analysis
3.3D BIOPRINTER TECHNOLOGIES
3.1.From 3D Printing to 3D Bioprinting
3.2.3D Bioprinting Technologies
3.2.1.Comparison of Key Specifications
3.3.3D Bioprinting Technology Comparison
3.4.Inkjet: Introduction
3.4.1.Inkjet: Key Specifications
3.4.2.Inkjet: Thermal
3.4.3.Inkjet: Piezoelectric
3.4.4.Inkjet: Advantages
3.4.5.Inkjet: Challenges
3.4.6.Inkjet: SWOT Analysis
3.5.Extrusion: Introduction
3.5.1.Extrusion: Key Specifications
3.5.2.Extrusion: Pneumatic
3.5.3.Extrusion: Mechanical
3.5.4.Extrusion: Advantages
3.5.5.Extrusion: Challenges
3.5.6.Extrusion: SWOT Analysis
3.6.Laser: Introduction
3.6.1.LIFT: Key Specifications
3.6.2.LIFT: Laser-Induced Forward Transfer
3.6.3.LIFT: Advantages
3.6.4.LIFT: Challenges
3.6.5.LIFT: SWOT Analysis
3.7.Microvalve: Introduction
3.7.1.Microvalve: Key Specifications
3.7.2.Microvalve: Solenoid
3.7.3.Microvalve: Advantages
3.7.4.Microvalve: Challenges
3.7.5.Microvalve: SWOT Analysis
3.8.Emerging Technology
3.8.1.Emerging Technology: Electrospinning
3.8.2.Emerging Technology: Microscale Continuous Optical Bioprinting (µCOB)
3.8.3.Emerging Technology: Paramagnetic and Acoustic
3.9.Industry-wide Technical Challenges
3.10.The Ideal 3D Bioprinter
3.11.Future Technological Directions
4.RELATED TECHNOLOGIES
4.1.Related Technologies
4.2.3D Bioprinting Software
4.3.Bioink Preparation
4.4.Cell Selection
4.4.1.Cell Selection: Regenerative Medicine
4.5.Growth Factors and Other Additives
4.6.Scaffold Materials
4.7.The Ideal Scaffold Material
4.8.Cell Spheroid Printing
4.9.Maturation
5.APPLICATIONS
5.1.Introduction
5.2.Testing of Cosmetics and Other Consumer Goods
5.3.Drug Screening
5.3.1.Drug Screening: Drug Development Process
5.3.2.Drug Screening: Benefits of 3D Bioprinting
5.4.Personalised Medicine
5.5.Regenerative Medicine
5.5.1.Regenerative Medicine: Tissue Roadmap
5.5.2.Regenerative Medicine: Bone and cartilage
5.5.3.Regenerative Medicine: Skin
5.5.4.Regenerative Medicine: Dental
5.5.5.Regenerative Medicine: Vasculature
5.5.6.Regenerative Medicine: Complex Organs
5.6.Cell-Based Biosensors
5.7.Food and Other Animal Products
5.8.Education
5.9.Academic Research
5.10.Bionics
6.MARKETS AND FORECASTS
6.1.Introduction
6.2.Growing 3D Bioprinting Market
6.3.Market Barriers
6.4.Key Losers
6.5.Forecasts
6.6.Overall 3D Bioprinting Market Forecast 2017 - 2027
6.6.1.Overall 3D Bioprinting Market Forecast: Short and Long Term
6.7.3D Bioprinting Value Chain
6.7.1.3D Bioprinting Value Chain: Discussion
6.8.3D Bioprinter Manufacturers
6.8.1.3D Bioprinters by Cost and Technology
6.9.3D Bioprinter Market Forecast 2017 - 2027
6.9.1.3D Bioprinter Market Forecast: Short Term
6.9.2.3D Bioprinter Market Forecast: Long Term
6.10.3D Bioprinting Service Bureaus
6.11.3D Bioprinted Tissue Forecast 2017 - 2027
6.11.1.3D Bioprinted Tissue Forecast: Consumer Products
6.11.2.3D Bioprinted Tissue Forecast: Pharmaceuticals
6.11.3.3D Bioprinted Tissue Forecast: Others
7.REGENERATIVE MEDICINE
7.1.Introduction
7.2.Regulatory Hurdles
7.3.Regenerative Medicine Advanced Therapy Designation
7.4.Ethics
7.5.Scams and Schemes
7.6.From Lab to Clinic
7.7.3D Bioprinting Roadmap to 2050
8.APPENDIX
8.1.List of 3D Bioprinting Companies
8.2.List of Company Profiles
8.2.1.3D Bioprinting Solutions/Vivax Bio
8.2.2.3Dynamic Systems Ltd
8.2.3.Aether Inc.
8.2.4.Aspect Biosystems
8.2.5.Biobots
8.2.6.BioDan Group
8.2.7.Cellenion SASU
8.2.8.Cellink
8.2.9.Digilab Inc.
8.2.10.GeSIM
8.2.11.Microdrop Technologies GmbH
8.2.12.MicroFab
8.2.13.Organovo Holdings, Inc.
8.2.14.PeptiGelDesign Ltd
8.2.15.Poietis
8.2.16.Regemat 3D
8.2.17.SE3D
8.2.18.Sichuan Revotek Co. Ltd.
 

About IDTechEx reports

What are the qualifications of the people conducting IDTechEx research?

Content produced by IDTechEx is researched and written by our technical analysts, each with a PhD or master's degree in their specialist field, and all of whom are employees. All our analysts are well-connected in their fields, intensively covering their sectors, revealing hard-to-find information you can trust.

How does IDTechEx gather data for its reports?

By directly interviewing and profiling companies across the supply chain. IDTechEx analysts interview companies by engaging directly with senior management and technology development executives across the supply chain, leading to revealing insights that may otherwise be inaccessible.
 
Further, as a global team, we travel extensively to industry events and companies to conduct in-depth, face-to-face interviews. We also engage with industry associations and follow public company filings as secondary sources. We conduct patent analysis and track regulatory changes and incentives. We consistently build on our decades-long research of emerging technologies.
 
We assess emerging technologies against existing solutions, evaluate market demand and provide data-driven forecasts based on our models. This provides a clear, unbiased outlook on the future of each technology or industry that we cover.

What is your forecast methodology?

We take into account the following information and data points where relevant to create our forecasts:
  • Historic data, based on our own databases of products, companies' sales data, information from associations, company reports and validation of our prior market figures with companies in the industry.
  • Current and announced manufacturing capacities
  • Company production targets
  • Direct input from companies as we interview them as to their growth expectations, moderated by our analysts
  • Planned or active government incentives and regulations
  • Assessment of the capabilities and price of the technology based on our benchmarking over the forecast period, versus that of competitive solutions
  • Teardown data (e.g. to assess volume of materials used)
  • From a top-down view: the total addressable market
  • Forecasts can be based on an s-curve methodology where appropriate, taking into account the above factors
  • Key assumptions and discussion of what can impact the forecast are covered in the report.

How can I be confident about the quality of work in IDTechEx reports?

Based on our technical analysts and their research methodology, for over 25 years our work has regularly received superb feedback from our global clients. Our research business has grown year-on-year.
 
Recent customer feedback includes:
"It's my first go-to platform"
- Dr. Didi Xu, Head of Foresight - Future Technologies, Freudenberg Technology Innovation
 
"Their expertise allows us to make data-driven, strategic decisions and ensures we remain aligned with the latest trends and opportunities in the market."
- Ralf Hug, Global Head of Product Management & Marketing, Marquardt

What differentiates IDTechEx reports?

Our team of in-house technical analysts immerse themselves in industries over many years, building deep expertise and engaging directly with key industry players to uncover hard-to-find insights. We appraise technologies in the landscape of competitive solutions and then assess their market demand based on voice-of-the-customer feedback, all from an impartial point of view. This approach delivers exceptional value to our customers—providing high-quality independent content while saving customers time, resources, and money.

Why should we pick IDTechEx research over AI research?

A crucial value of IDTechEx research is that it provides information, assessments and forecasts based on interviews with key people in the industry, assessed by technical experts. AI is trained only on content publicly available on the web, which may not be reliable, in depth, nor contain the latest insights based on the experience of those actively involved in a technology or industry, despite the confident prose.

How can I justify the ROI of this report?

Consider the cost of the IDTechEx report versus the time and resources required to gather the same quality of insights yourself. IDTechEx analysts have built up an extensive contact network over many years; we invest in attending key events and interviewing companies around the world; and our analysts are trained in appraising technologies and markets.
 
Each report provides an independent, expert-led technical and market appraisal, giving you access to actionable information immediately, rather than you having to spend months or years on your own market research.

Can I speak to analysts about the report content?

All report purchases include up to 30 minutes of telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

What is the difference between a report and subscription?

A subscription from IDTechEx can include more reports, access to an online information platform with continuously updated information from our analysts, and access to analysts directly.

Before purchasing, I have some questions about the report, can I speak to someone?

Please email research@idtechex.com stating your location and we will quickly respond.

About IDTechEx

Who are IDTechEx's customers?

IDTechEx has served over 35,000 customers globally. These range from large corporations to ambitious start-ups, and from Governments to research centers. Our customers use our work to make informed decisions and save time and resources.

Where is IDTechEx established?

IDTechEx was established in 1999, and is headquartered in Cambridge, UK. Since then, the company has significantly expanded and operates globally, having served customers in over 80 countries. Subsidiary companies are based in the USA, Germany and Japan.

Questions about purchasing a report

How do I pay?

In most locations reports can be purchased by credit card, or else by direct bank payment.

How and when do I receive access to IDTechEx reports?

When paying successfully by credit card, reports can be accessed immediately. For new customers, when paying by bank transfer, reports will usually be released when the payment is received. Report access will be notified by email.

How do I assign additional users to the report?

Users can be assigned in the report ordering process, or at a later time by email.

Can I speak to someone about purchasing a report?

Please email research@idtechex.com stating your location and we will quickly respond.
 
The market for 3D bioprinting will reach $1.8 billion by 2027

Report Statistics

Slides 184
Companies 18
Forecasts to 2027
 

Customer Testimonial

quote graphic
"The resources produced by IDTechEx are a valuable tool... Their insights and analyses provide a strong foundation for making informed, evidence-based decisions. By using their expertise, we are better positioned to align our strategies with emerging opportunities."
Director of Market Strategy
Centre for Process Innovation (CPI)
 
 
 

Subscription Enquiry